Planet Pharma SA Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Planet Pharma SA Pharmaceutical Import Records from India — 15 Products, $20.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Planet Pharma SA — Pharmaceutical Importer Profile (2026) | 15 Products, $20.2M Trade | TransData Nexus

Planet Pharma SA

Pharmaceutical Importer · France · Advanced Antibiotics Focus · $20.2M Total Trade · DGFT Verified

Planet Pharma SA is a pharmaceutical importer based in France with a total trade value of $20.2M across 15 products in 10 therapeutic categories. Based on 617 verified import shipments from Indian Customs (DGFT) records, Planet Pharma SA is the #1 buyer in 2 products including Vildagliptin, Bhasma. Planet Pharma SA sources from 14 verified Indian suppliers, with Ajanta Pharma Limited accounting for 87.7% of imports.

Planet Pharma SA — Import Portfolio & Supplier Network

Planet Pharma SA import network — 15 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Planet Pharma SA?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Ajanta Pharma Limited	$62.0M	3,535	87.7%
Sun Pharmaceutical Industries Limited	$2.6M	146	3.6%
Gepach International	$1.6M	93

What Formulations Does Planet Pharma SA Import?

Formulation	Value	Ships
Fedate syrup, 200ML[19488 x 1 = 19488	$508.6K	14
Fixim oral suspension 60 ML[cefexime	$492.4K	11
Levotop 500MG tablet[levofloxacine	$460.9K	12
Artefan pfos 20/120MG artefan	$345.2K	11
Brustan suspension Each 5ML contains: ibuprofen BP 100MG paracetamol BP 125MG Pack:100 ML batch no as per	$318.7K	15
Apdyl-h syrup, 100ML[39000 x 1 = 39000	$299.6K	7
Cetazone 1GM injection[ceftriaxone for	$269.4K	7
Amaday pl TAB 10/4MG[amlodipine and	$256.9K	8
Apdyl-h syrup, 100ML[66660 x 1 = 66660	$250.0K	5
Apdyl-h syrup, 100ML [66660 x 1 =	$250.0K	5
Ranferon 12 elixir Each 5ML contains ferric ammonuim citrate 200MG equivalent to41 MG of elemental iron folic acid	$242.6K	10
Apdyl-h syrup, 100ML[80640 x 1 = 80640 bottles][herbal cough syrup]packing: 100/200ML Each 10ML contains:as per	$242.2K	7
Fixim oral suspension 60ML[cefexime	$233.0K	5
Apramol 500MG effervescent	$200.0K	4
Biba syrup,100ML[multivitamin	$200.0K	4

Planet Pharma SA imports 2,555 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 15 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Kit	Medical Devices & Diagnostics	$3.8M	86	0.9%	4
2	Artemether	Antimalarial & Antiparasitic	$3.4M	135	0.4%	14
3	Vitamin	Nutritional Supplements	$2.3M	61	1.6%	6
4	Ceftriaxone	Advanced Antibiotics	$1.9M	58	0.7%	13
5	Azithromycin	Antibiotics	$1.8M	52	1.0%	13
6	Vildagliptin	Advanced Diabetes Medications	$1.4M	48	14.1%	1
7	Levofloxacin	Antibiotics	$973.7K	26	1.3%	11
8	Fluconazole	Antifungals	$900.0K	18	1.0%	11
9	Secnidazole	Advanced Antibiotics	$900.0K	18	3.0%	3
10	Flucloxacillin	Advanced Antibiotics	$777.3K	65	2.0%	8
11	Atenolol	Cardiovascular	$600.0K	12	1.5%	10
12	Vati	Ayurvedic & Herbal Products	$491.4K	12	1.9%	13
13	Aspirin	Analgesics & Antipyretics	$460.3K	12	1.2%	15
14	Moxifloxacin	Advanced Antibiotics	$341.8K	12	1.0%	13
15	Bhasma	Ayurvedic & Herbal Products	$30.8K	2	7.4%	1

Planet Pharma SA imports 15 pharmaceutical products across 10 categories into France totaling $20.2M. The company is the #1 buyer for 2 products: Vildagliptin, Bhasma.

Planet Pharma SA — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Planet Pharma SA is a French pharmaceutical importer and distributor headquartered in Le Grand Quevilly, Normandy, France. As a subsidiary of the UbiPharm group, Planet Pharma SA plays a pivotal role in the distribution and availability of pharmaceutical products within France and across various African markets. The company specializes in the import and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, ensuring compliance with good distribution practices.

With a storage capacity of 37,000 pallets across two automated platforms, Planet Pharma SA manages the distribution of over 100 pharmaceutical laboratories to 150 wholesaler-distributor customers in 23 African countries. This extensive network underscores its significant presence in the pharmaceutical supply chain, facilitating the efficient delivery of medicines to diverse markets.

2Distribution Network

Planet Pharma SA operates two storage platforms in France, covering a combined area of 25,000 square meters with a capacity of 37,000 pallets. These facilities are equipped with automated systems that enable rapid storage and preparation operations, ensuring compliance with good distribution practices. Strategically located near the ports of Rouen and Le Havre, the company has access to major shipping routes, facilitating efficient logistics for both domestic and international shipments.

Beyond France, Planet Pharma SA extends its distribution reach to 23 African countries, serving 150 wholesaler-distributor customers. This extensive network highlights the company's capability to manage complex logistics and supply chain operations across diverse geographies.

3Industry Role

In France's pharmaceutical supply chain, Planet Pharma SA functions as a primary wholesaler and distributor, specializing in the import and export of finished pharmaceutical formulations. The company's dual status as a wholesale distributor for exports and a pharmaceutical depot enables it to oversee the entire distribution process, from procurement to delivery, ensuring the availability of medicines in both domestic and international markets.

Additionally, Planet Pharma SA is responsible for managing regulatory affairs, including the registration and maintenance of marketing authorizations for drugs, in compliance with the regulations in force. This role underscores its integral position in ensuring that pharmaceutical products meet the necessary standards and are accessible to the intended markets.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Planet Pharma SA

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Planet Pharma SA's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a limited number of suppliers. The company's total import value from India stands at $20.2 million USD, encompassing 617 shipments across 15 products from 14 unique suppliers. Notably, Ajanta Pharma Limited is the predominant supplier, accounting for 87.7% of the total import value with 3,535 shipments.

This concentrated sourcing approach may present risks related to supply chain disruptions, such as production delays or quality control issues. However, the stability of the relationship with Ajanta Pharma Limited, as evidenced by the extensive number of shipments, suggests a strategic partnership aimed at ensuring consistent product availability. The company's diversified supplier base, including other Indian manufacturers, provides a buffer against potential disruptions from any single source.

2Supply Chain Resilience

Planet Pharma SA's supply chain resilience is bolstered by its diversified supplier base, encompassing 14 unique suppliers from India. This diversity mitigates the risks associated with over-reliance on a single supplier. The company's strategic location near major ports in Le Havre and Rouen enhances its logistical capabilities, facilitating efficient import and export operations.

Additionally, Planet Pharma SA's adherence to good distribution practices and its status as an Authorized Economic Operator (AEO) reflect a commitment to regulatory compliance and operational excellence. These factors collectively contribute to the robustness and reliability of its supply chain operations.

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the National Agency for the Safety of Medicines and Health Products (ANSM). ANSM is responsible for ensuring the safety, efficacy, and quality of health products, including pharmaceuticals, medical devices, and cosmetics. The agency's role encompasses the evaluation and monitoring of medicines, as well as the regulation of their distribution within the French market.

Key legislation governing pharmaceutical imports into France includes the Public Health Code (Code de la santé publique) and the European Union's directives and regulations pertaining to medicinal products. These legal frameworks establish the requirements for marketing authorizations, importation procedures, and the responsibilities of stakeholders within the pharmaceutical supply chain.

For Indian generics to enter the French market, they must undergo a marketing authorization process, which involves the submission of comprehensive data on the product's quality, safety, and efficacy. This process ensures that imported medicines meet the stringent standards set by ANSM and the European Medicines Agency (EMA), facilitating their availability to patients in France.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in France are stringent, necessitating that all imported medicines possess a valid marketing authorization issued by ANSM. This authorization confirms that the product has been evaluated and approved for sale within the French market.

Planet Pharma SA — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Planet Pharma SA's product category focus is strategically aligned with market demand and therapeutic needs. The company's top three therapeutic categories—Advanced Antibiotics (19.6%), Medical Devices & Diagnostics (18.7%), and Antimalarial & Antiparasitic (16.9%)—reflect a commitment to addressing critical health challenges. The substantial import values of key products such as Kit ($3.8M), Artemether ($3.4M), Vitamin ($2.3M), Ceftriaxone ($1.9M), and Azithromycin ($1.8M) underscore the company's role in supplying essential medicines to the French and African markets.

The focus on these therapeutic areas is driven by the prevalence of infectious diseases and the need for effective treatments in both regions. By prioritizing these categories, Planet Pharma SA ensures the availability of critical medications, contributing to improved health outcomes.

2Sourcing Profile

Planet Pharma SA's sourcing strategy emphasizes the importation of generic drugs, particularly from India, which is known for its robust pharmaceutical manufacturing sector. The company's preference for finished pharmaceutical formulations aligns with its commitment to providing ready-to-use medicines that meet international quality standards.

India's role as a key supplier is integral to Planet Pharma SA's procurement strategy, offering a diverse range of generic products that cater to various therapeutic needs. The company's sourcing profile reflects a strategic approach to ensuring the availability of essential medicines while maintaining cost

Frequently Asked Questions — Planet Pharma SA

What products does Planet Pharma SA import from India?

Planet Pharma SA imports 15 pharmaceutical products across 10 categories. Top imports: Kit ($3.8M), Artemether ($3.4M), Vitamin ($2.3M), Ceftriaxone ($1.9M), Azithromycin ($1.8M).

Who supplies pharmaceuticals to Planet Pharma SA from India?

Planet Pharma SA sources from 14 verified Indian suppliers. The primary supplier is Ajanta Pharma Limited (87.7% of imports, $62.0M).

What is Planet Pharma SA's total pharmaceutical import value?

Planet Pharma SA's total pharmaceutical import value from India is $20.2M, based on 617 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Planet Pharma SA focus on?

Planet Pharma SA imports across 10 categories. The largest: Advanced Antibiotics (19.6%), Medical Devices & Diagnostics (18.7%), Antimalarial & Antiparasitic (16.9%).

Get Full Planet Pharma SA Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.